Today, Blueberry Therapeutics published our latest peer-reviewed scientific paper. The paper entitled “Assessment of the nail penetration of antifungal agents, with different physico-chemical properties” was published in PLoS One ( and describes our research into antifungal drugs and their ability to penetrate through human nail. We demonstrate the importance of “water solubility” in dictating the ability of drugs to effectively pass through nail, supporting observations made in other research labs. Chief Scientific Officer, David Cook said “These findings may lead to important new thinking in drug design for nail diseases. It is also great for us to be able to get this research out to the broader scientific community.  This is just one project amongst many exciting programmes at Blueberry and we hope we’ll be sharing more of our research from the team soon.”